全体要約
関連する質問
4.80 billion USD (2022)
22.68% (2023-2030)
Quest Diagnostics Incorporated, ARUP Laboratories, Applied Biological Materials, Inc. (abm), Novogene Co, Ltd., Azenta Life Sciences (GENEWIZ), NanoString Technologies, Inc., Illumina, Inc., PacBio, Veritas Technologies LLC., BGI (Beijing Genomics Institute)
自動化の進歩, NGS技術のコスト低下, 遺伝性疾患の増加
概要
目次
Description
Table of Contents
